Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02047149
Title Evaluating the Safety of Zileuton (Zyflo(R)) in Combination With Dasatinib (Sprycel (R) in Chronic Myelogenous Leukemia
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Massachusetts, Worcester

chronic myeloid leukemia


Dasatinib + Zileuton

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.